Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Heterogeneous Genetic Alterations and Novel Pathogenic Pathways in Relapsed DLBCL Revealed By Whole Exome Sequencing

Jiao Ma, PhD, Kui Nie, PhD, Giorgio Inghirami, MD, Kenneth Eng, B.S., Olivier Elemento, PhD, Rex Au-Yeung, Yajie Shen, BSA, Gopesh Srivastava, Jerald Gong, MD, Mina L Xu, MD, Leonard H.C. Tan, Wayne Tam, MD PhD

Blood (2019) 134 (Supplement_1): 2770.

https://doi.org/10.1182/blood-2019-125448

Published: 2019

Journal Articles

Defining the Cell Surface Proteome of MLL Rearranged Leukemia

Matthew Nix, PhD, Arun P. Wiita, MD PhD

Blood (2017) 130 (Supplement 1): 3971.

https://doi.org/10.1182/blood.V130.Suppl_1.3971.3971

Published: 2017

Journal Articles

Calvariae-Resident Osteomacs That Are Phenotypically and Functionally Distinct from Marrow-Derived Macrophages Interact with Megakaryocytes to Regulate Hematopoietic Stem Cell Function

Safa F Mohamad, Linlin Xu, Himes R Evan, Hao Wu, Marta Alvarez, Paul Childress, Korbin Davis, Melissa Kacena, Edward F. Srour, PhD

Blood (2016) 128 (22): 28.

https://doi.org/10.1182/blood.V128.22.28.28

Published: 2016

Journal Articles

EphA3 Is Expressed on Leukemia Stem Cells, and Eph/Ephrin Signalling Features in the Remodelling of the Leukemia Stem Cell Niche

Christopher I Slape, PhD

Blood (2014) 124 (21): 4783.

https://doi.org/10.1182/blood.V124.21.4783.4783

Published: 2014

Journal Articles

Immunotherapeutic Targeting of EphA3

Sara Charmsaz, Kirrilee J Miller, Bryan W Day, PhD, Fares El-Ajeh, PhD, Varghese Palath, PhD, Geoff T Yarranton, PhD, Christopher R Bebbington, DPhil., Andrew M Scott, PhD, Martin Lackmann, PhD, Andrew W Boyd, MD PhD

Blood (2014) 124 (21): 3720.

https://doi.org/10.1182/blood.V124.21.3720.3720

Published: 2014

Journal Articles

An IHC Screen for EphA3 Positive Myelofibrosis (MF) and Other Myeloproliferative Neoplasms (MPNs)

Darren Locke, PhD, Frank Lynch, PhD, Steven Bernstein, PhD, Koushan Siami-Namini, MD FCAP, Geoff T Yarranton, PhD

Blood (2014) 124 (21): 5588.

https://doi.org/10.1182/blood.V124.21.5588.5588

Published: 2014

Journal Articles

EphB1 Downregulation In Acute Myeloid Leukemia: Suppressing p53-Dependent DNA Damage Control System

Kim R Kampen, Frank JG Scherpen, Guillermo Garcia-Manero, MD, Hui Yang, MD, PhD., Steven M. Kornblau, MD, Evelina S.J.M. de Bont, MD, PhD

Blood (2013) 122 (21): 2484.

https://doi.org/10.1182/blood.V122.21.2484.2484

Published: 2013

Journal Articles

EphA3 As a Molecular Target In Multiple Myeloma: Opportunity For a Novel Therapeutic Approach With a Specific Monoclonal Antibody

Blood (2013) 122 (21): 3211.

https://doi.org/10.1182/blood.V122.21.3211.3211

Published: 2013

Journal Articles

Hypoxia Regulates Eph/Ephrin-Facilitated Adhesion and Proliferation Of Chronic Myeloid Leukemia Cells

Xuan Zhou, Liu Xiaoli, MD, Na Xu, Yajuan Xiao, Zhengshan Yi, Guanlun Gao, Jinfang Zhang, Bintao Huang, Qingfeng Du

Blood (2013) 122 (21): 5165.

https://doi.org/10.1182/blood.V122.21.5165.5165

Published: 2013

Journal Articles

An IHC Screen For EphA3 Positive FFPE Tumors

Darren Locke, PhD, Steven Bernstein, PhD, Frank Lynch, PhD, Koushan Siami-Namini, MD, FCAP, Jackie M. Walling, MBChB, PhD, Thomas Yonker, Geoffrey Yarranton, PhD

Blood (2013) 122 (21): 4965.

https://doi.org/10.1182/blood.V122.21.4965.4965

Published: 2013

Journal Articles

Activation Of EphrinB2/EphB4 Influences Myeloid Leukemia Cell Migration and Invasion

Xuan Zhou, Liu Xiaoli, MD, Na Xu, Yajuan Xiao, Jinfang Zhang, Bintao Huang, Qingfeng Du

Blood (2013) 122 (21): 1360.

https://doi.org/10.1182/blood.V122.21.1360.1360

Published: 2013

Journal Articles

Activation of the EfnB1/EphB1 Forward Signaling Promotes Cell Cycle Arrest in Acute Myeloid Leukemia Cells

Kim R Kampen, Arja ter Elst, PhD, Evelina S. De Bont, MD, PhD

Blood (2012) 120 (21): 4719.

https://doi.org/10.1182/blood.V120.21.4719.4719

Published: 2012

Journal Articles

Eph-A4 Plays a Important Role in Metastasis and Invasive Activity of Myeloid Leukemia Cells

Liu Xiaoli, MD, Xuan Zhou, Yuan Zuo, Lulu Xu, Jinfang Zhang, Na Xu, Bintao Huang, Xiaozhen Xiao, Yuanlu Huang, Qingfeng Du

Blood (2012) 120 (21): 4819.

https://doi.org/10.1182/blood.V120.21.4819.4819

Published: 2012

Journal Articles

Identification of EpHA3 As a New Potential Molecular Target in Multiple Myeloma.

Antonella Caivano, Francesco La Rocca, Alessandra Favole, PhD, Sonia Carturan, PhD, Enrico Bracco, PhD, Oreste Villani, Giuseppe Pietrantuono, Ilaria Laurenzana, Luciana De Luca, MD, Annalisa Morano, Vittorio Simeon, Stefania Trino, Simona Berardi, Antonio Basile, Angelo Vacca, Pellegrino Musto, Daniela Cilloni, MD

Blood (2012) 120 (21): 2926.

https://doi.org/10.1182/blood.V120.21.2926.2926

Published: 2012

Journal Articles

EphrinB1 Activation As a Potential New Treatment Option in AML

Arja ter Elst, PhD, Kim R Kampen, Sander H Diks, PhD, Steven M. Kornblau, MD, Guillermo Garcia-Manero, Evelina S. De Bont, MD, PhD

Blood (2011) 118 (21): 5235.

https://doi.org/10.1182/blood.V118.21.5235.5235

Published: 2011

Journal Articles

Eph-B2/Ephrin-B2 Interaction Plays a Major Role In the Adhesion and Survival of WM Cells In the Context of the Bone Marrow Microenvironment

Feda Azab, Abdel Kareem A. Azab, PhD, BSPharm, Patricia Maiso, Phong Quang, Aldo M. Roccaro, MD, PhD, Antonio Sacco, Hai T Ngo, Yang Liu, PhD, Yong Zhang, PhD, Brittany Morgan, Irene M. Ghobrial, MD

Blood (2010) 116 (21): 142.

https://doi.org/10.1182/blood.V116.21.142.142

Published: 2010

Journal Articles

Mechanisms of Heme Oxygenase 1-Induced Resistance to Imatinib In CML Cells.

Daniele Tibullo, Ignazio Barbagallo, Antonio Branca, Cesarina Giallongo, Piera La Cava, PhD, Nunziatina Parrinello, Giovanni Li Volti, Angelo Vanella, Fabio Stagno, MD, Giuseppe A Palumbo, MD, Francesco Di Raimondo

Blood (2010) 116 (21): 3385.

https://doi.org/10.1182/blood.V116.21.3385.3385

Published: 2010

Journal Articles

Eph-B2 Receptor Tyrosine Kinase Is Overexpressed in Waldenstrom's Macroglubulinemia and Plays a Major Role in Its Interaction with the Bone Marrow Microenvironment.

Abdel Kareem Azab, Bpharm, PhD, Feda Azab, BPharm, Aldo M. Roccaro, MD, PhD, Antonio Sacco, Phong Quang, Hai T. Ngo, Molly R Melhem, Judith M. Runnels, PhD, Patricia Maiso, PhD, Irene M. Ghobrial, M.D.

Blood (2009) 114 (22): 2935.

https://doi.org/10.1182/blood.V114.22.2935.2935

Published: 2009

Journal Articles

EphA3 Kinase Is Constitutively Activated in Chronic Myeloid Leukaemia during Progression to Accelerated and Blast Crisis and It Could Represent a New Molecular Target.

Daniela Cilloni, MD, PhD, Francesca Arruga, PhD, Sonia Carturan, PhD, Francesca Messa, PhD, Monica Pradotto, PhD, Ilaria Defilippi, PhD, Marisa Pautasso, MD, Ilaria Iacobucci, PhD, Giovanni Martinelli, MD, Enrico Bracco, PhD, Thea Kalebic, MD, Martin Lackmann, PhD, Giuseppe Saglio, MD

Blood (2008) 112 (11): 1092.

https://doi.org/10.1182/blood.V112.11.1092.1092

Published: 2008

Journal Articles

Eph Receptor Tyrosine Kinases and Ephrin Ligands Are Epigenetically Inactivated in Acute Lymphoblastic Leukemia and Are Potential New Tumor Suppressor Genes in Human Leukemia.

Shao-qing Kuang, MD, PhD, Zhi-Hong Fang, PhD, Gonzalo Lopez, Weigang Tong, MD, PhD, Hui Yang, MD, PhD, Guillermo Garcia-Manero, MD

Blood (2007) 110 (11): 2128.

https://doi.org/10.1182/blood.V110.11.2128.2128

Published: 2007

NARROW

Heterogeneous Genetic Alterations and Novel Pathogenic Pathways in Relapsed DLBCL Revealed By Whole Exome Sequencing

Defining the Cell Surface Proteome of MLL Rearranged Leukemia

Calvariae-Resident Osteomacs That Are Phenotypically and Functionally Distinct from Marrow-Derived Macrophages Interact with Megakaryocytes to Regulate Hematopoietic Stem Cell Function

EphA3 Is Expressed on Leukemia Stem Cells, and Eph/Ephrin Signalling Features in the Remodelling of the Leukemia Stem Cell Niche

Immunotherapeutic Targeting of EphA3

An IHC Screen for EphA3 Positive Myelofibrosis (MF) and Other Myeloproliferative Neoplasms (MPNs)

EphB1 Downregulation In Acute Myeloid Leukemia: Suppressing p53-Dependent DNA Damage Control System

EphA3 As a Molecular Target In Multiple Myeloma: Opportunity For a Novel Therapeutic Approach With a Specific Monoclonal Antibody

Hypoxia Regulates Eph/Ephrin-Facilitated Adhesion and Proliferation Of Chronic Myeloid Leukemia Cells

An IHC Screen For EphA3 Positive FFPE Tumors

Activation Of EphrinB2/EphB4 Influences Myeloid Leukemia Cell Migration and Invasion

Activation of the EfnB1/EphB1 Forward Signaling Promotes Cell Cycle Arrest in Acute Myeloid Leukemia Cells

Eph-A4 Plays a Important Role in Metastasis and Invasive Activity of Myeloid Leukemia Cells

Identification of EpHA3 As a New Potential Molecular Target in Multiple Myeloma.

EphrinB1 Activation As a Potential New Treatment Option in AML

Eph-B2/Ephrin-B2 Interaction Plays a Major Role In the Adhesion and Survival of WM Cells In the Context of the Bone Marrow Microenvironment

Mechanisms of Heme Oxygenase 1-Induced Resistance to Imatinib In CML Cells.

Eph-B2 Receptor Tyrosine Kinase Is Overexpressed in Waldenstrom's Macroglubulinemia and Plays a Major Role in Its Interaction with the Bone Marrow Microenvironment.

EphA3 Kinase Is Constitutively Activated in Chronic Myeloid Leukaemia during Progression to Accelerated and Blast Crisis and It Could Represent a New Molecular Target.

Eph Receptor Tyrosine Kinases and Ephrin Ligands Are Epigenetically Inactivated in Acute Lymphoblastic Leukemia and Are Potential New Tumor Suppressor Genes in Human Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only